Search

Your search keyword '"Robalo-Cordeiro, C."' showing total 337 results

Search Constraints

Start Over You searched for: Author "Robalo-Cordeiro, C." Remove constraint Author: "Robalo-Cordeiro, C."
337 results on '"Robalo-Cordeiro, C."'

Search Results

1. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

2. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

5. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

7. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

8. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

9. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

10. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

11. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

12. Operational definition of Active and Healthy Ageing (AHA): A conceptual framework

13. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

14. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

15. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

16. Issue 1 - 'Update on adverse respiratory effects of outdoor air pollution' Part 2): Outdoor air pollution and respiratory diseases: Perspectives from Angola, Brazil, Canada, Iran, Mozambique and Portugal

17. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

18. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

19. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

20. Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study

22. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

23. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

24. The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach

25. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

26. Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease

27. Pandemia COVID-19 e Impacto no Desporto

28. The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach

29. The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach

32. Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good

36. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

37. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

38. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

39. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

40. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

41. Idiopathic pulmonary fibrosis: Best practice in monitoring and managing a relentless fibrotic disease

42. Trauma

43. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

44. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

45. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

46. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

47. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

48. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

49. A Portuguese survey

50. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Catalog

Books, media, physical & digital resources